Archive: 02/04/2018
Combination immunotherapy improves survival in mouse models of mesothelioma
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer ...
Apr 2, 2018
Researchers find new trigger for onset of colon cancer, which may lead to better therapies
Colon cancer is the second most common cause of cancer-related deaths. The APC protein has long been known for its critical role in preventing colorectal cancer. When APC is inactivated, the development of colorectal cancer ...
Apr 2, 2018